Cargando…
Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT- 9K/129G
PT-9K/129G, a nontoxic mutant of pertussis toxin (PT) obtained by genetic manipulation, has been shown in animal models to be a promising candidate for new vaccines against whooping cough. To assess the safety and the immunogenicity of PT-9K/129G in humans, a pilot study has been performed in adult...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188543/ https://www.ncbi.nlm.nih.gov/pubmed/2201750 |
Ejemplares similares
-
Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT)
por: Lee, Adria D., et al.
Publicado: (2018) -
Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange
por: Buasri, Wasin, et al.
Publicado: (2012) -
Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
por: Lee, Soo Young, et al.
Publicado: (2014) -
Association of Pertussis Toxin with Severe Pertussis Disease
por: Scanlon, Karen, et al.
Publicado: (2019) -
Secretion of Pertussis Toxin from Bordetella pertussis
por: Burns, Drusilla L.
Publicado: (2021)